PharmaCorp Rx Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	12.89	2.24	2.73	0.98
Cash & Short-Term Investments	12.89	2.24	2.73	0.98
Cash Growth	474.84%	-17.99%	178.91%	-
Receivables	0.33	-	-	-
Inventory	1.31	-	-	-
Prepaid Expenses	0.05	-	-	-
Other Current Assets	-	0.08	-	0.02
Total Current Assets	14.57	2.32	2.73	1
Property, Plant & Equipment	4.02	-	-	-
Goodwill	11.48	-	-	-
Other Intangible Assets	5.13	-	-	-
Total Assets	35.21	2.32	2.73	1
Accounts Payable	1.54	0.05	0.02	0.03
Current Portion of Long-Term Debt	0.08	-	-	-
Current Portion of Leases	0.07	-	-	-
Current Income Taxes Payable	0.01	-	-	-
Total Current Liabilities	1.7	0.05	0.02	0.03
Long-Term Debt	0.32	-	-	-
Long-Term Leases	0.49	-	-	-
Long-Term Deferred Tax Liabilities	2.14	-	-	-
Total Liabilities	4.64	0.05	0.02	0.03
Common Stock	31.7	2.8	2.74	1
Additional Paid-In Capital	0.67	0.49	0.52	-
Retained Earnings	-2.03	-1.01	-0.54	-0.03
Total Common Equity	30.34	2.27	2.72	0.97
Minority Interest	0.22	-	-	-
Shareholders' Equity	30.57	2.27	2.72	0.97
Total Liabilities & Equity	35.21	2.32	2.73	1
Total Debt	0.95	-	-	-
Net Cash (Debt)	11.93	2.24	2.73	0.98
Net Cash Growth	432.33%	-17.99%	178.91%	-
Net Cash Per Share	0.15	0.11	0.14	0.06
Filing Date Shares Outstanding	115.3	20.28	20	16.17
Total Common Shares Outstanding	115.3	20.28	20	16.17
Working Capital	12.88	2.27	2.72	0.97
Book Value Per Share	0.26	0.11	0.14	0.06
Tangible Book Value	13.73	2.27	2.72	0.97
Tangible Book Value Per Share	0.12	0.11	0.14	0.06
Land	0.25	-	-	-
Buildings	2.85	-	-	-
Machinery	0.13	-	-	-
Leasehold Improvements	0.31	-	-	-

Updated Nov 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.